drugset / Trial / NCT06277284
Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects
Unknown
60 enrolled
Shanghai Mabgeek Biotech.Co.Ltd
The Second Hospital of Anhui Medical University · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
Research Topics A randomized, open-label, parallel-group, phase I clinical trial comparing the pharmacokinetics of MG-K10 humanized monoclonal antibody in healthy adults
Timeline
- Start
- 2023-10-23
- Primary completion
- 2024-01-26
- Completion
- 2024-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | COMEKIBART | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.